$52.02B
Revenue
$10.05B
Net Income
39.75%
Gross Margin
10.70%
Op. Margin
$16.74B
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Total Revenue | $52.02B | $52.02B | $43.98B | $37.28B | $31.88B | $17.45B |
| Revenue Growth % | 0.0% | 18.3% | 18.0% | 17.0% | 82.6% | nan% |
| Cost of Revenue | $31.34B | $31.34B | $26.65B | $22.46B | $19.66B | $9.35B |
| Gross Profit | $20.68B | $20.68B | $17.33B | $14.82B | $12.22B | $8.10B |
| Gross Margin % | 39.8% | 39.8% | 39.4% | 39.8% | 38.3% | 46.4% |
| Operating Expenses | $46.45B | $46.45B | $41.18B | $36.17B | $33.71B | $21.29B |
| Research & Development | $3.40B | $3.40B | $3.11B | $3.16B | $2.80B | $2.05B |
| Operating Income | $5.57B | $5.57B | $2.80B | $1.11B | $-1.83B | $-3.83B |
| Operating Margin % | 10.7% | 10.7% | 6.4% | 3.0% | -5.7% | -22.0% |
| Interest Expense | $747.00M | $386.00M | $475.00M | $633.00M | $565.00M | $483.00M |
| Interest Income | - | $743.00M | $721.00M | $484.00M | - | - |
| Other Income/Expense | $-68.00M | $-68.00M | $1.13B | $1.36B | $-7.03B | $3.29B |
| Income Before Tax | $5.80B | $5.80B | $4.12B | $2.32B | $-9.43B | $-1.02B |
| Income Tax Expense | $-4.35B | $-4.35B | $-5.76B | $213.00M | $-181.00M | $-492.00M |
| Net Income | $10.05B | $10.05B | $9.86B | $1.89B | $-9.14B | $-496.00M |
| Net Margin % | 19.3% | 19.3% | 22.4% | 5.1% | -28.7% | -2.8% |
| Basic EPS | 4.83 | 4.82 | 4.71 | 0.93 | -4.64 | -0.26 |
| Diluted EPS | 4.73 | 4.73 | 4.56 | 0.87 | -4.65 | -0.29 |
| Basic Shares Outstanding | - | 2.09B | 2.09B | 2.04B | 1.97B | 1.89B |
| Diluted Shares Outstanding | - | 2.12B | 2.15B | 2.09B | 1.97B | 1.90B |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.11B | $5.89B | $4.68B | $4.21B | $4.29B |
| Short-term Investments | $528.00M | $1.08B | $727.00M | $103.00M | - |
| Accounts Receivable | $3.83B | $3.33B | $3.40B | $2.78B | $2.44B |
| Other Current Assets | $1.49B | $975.00M | $1.68B | $1.48B | $1.45B |
| Total Current Assets | $13.99B | $12.24B | $11.30B | $9.25B | $8.82B |
| Property Plant & Equipment | - | - | $2.07B | $2.08B | $1.85B |
| Goodwill | $8.93B | $8.07B | $8.15B | $8.26B | $8.42B |
| Intangible Assets | $1.05B | $1.12B | $1.43B | $1.87B | $2.41B |
| Other Non-current Assets | $3.62B | $2.57B | $1.76B | $518.00M | $397.00M |
| Total Assets | $61.80B | $51.24B | $38.70B | $32.11B | $38.77B |
| Accounts Payable | $1.01B | $858.00M | $790.00M | $728.00M | $860.00M |
| Accrued Liabilities | - | - | $6.46B | $6.23B | $6.54B |
| Other Current Liabilities | $2.26B | $2.19B | - | - | - |
| Total Current Liabilities | $12.32B | $11.48B | $9.45B | $8.85B | $9.02B |
| Long-term Debt | $10.60B | $8.35B | $9.46B | $9.27B | $9.28B |
| Deferred Tax Liabilities | $31.00M | $9.00M | - | - | - |
| Other Non-current Liabilities | $412.00M | $449.00M | $832.00M | $786.00M | $935.00M |
| Total Liabilities | $33.72B | $28.77B | $26.02B | $23.61B | $23.43B |
| Common Stock | - | - | - | - | - |
| Retained Earnings | $-10.63B | $-20.73B | $-30.59B | $-32.77B | $-23.63B |
| Total Stockholders Equity | $27.04B | $21.56B | $11.25B | $7.34B | $14.46B |
| Total Liabilities & Equity | $61.80B | $51.24B | $38.70B | $32.11B | $38.77B |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
FY 2022 (Dec 31, 2022) |
FY 2021 (Dec 31, 2021) |
|---|---|---|---|---|---|---|
| Net Income | $11.83B | $10.05B | $9.86B | $1.89B | $-9.14B | $-496.00M |
| Depreciation & Amortization | $719.00M | $719.00M | $711.00M | $823.00M | $947.00M | $902.00M |
| Stock-based Compensation | $3.17B | $1.83B | $1.80B | $1.94B | $1.79B | $1.17B |
| Deferred Income Tax | $-5.52B | $-4.78B | $-6.03B | $26.00M | $-441.00M | $-692.00M |
| Change in Receivables | $924.00M | $466.00M | $142.00M | $758.00M | $542.00M | $597.00M |
| Change in Payables | $263.00M | $126.00M | $86.00M | $64.00M | $-133.00M | $90.00M |
| Operating Cash Flow | $17.31B | $10.10B | $7.14B | $3.58B | $642.00M | $-445.00M |
| Capital Expenditure | $573.00M | $336.00M | $242.00M | $223.00M | $252.00M | $298.00M |
| Acquisitions | - | $815.00M | - | - | $59.00M | $2.31B |
| Purchases of Investments | $31.62B | $21.45B | $12.77B | $8.77B | $1.71B | $1.11B |
| Investing Cash Flow | $-6.11B | $-3.56B | $-3.18B | $-3.23B | $-1.64B | $-1.20B |
| Debt Repayment | $2.35B | $2.35B | $3.99B | $2.67B | - | $27.00M |
| Stock Repurchased | $11.46B | $6.52B | $1.25B | - | - | - |
| Financing Cash Flow | $-9.63B | $-5.71B | $-2.09B | $-95.00M | $15.00M | $1.78B |
| Net Change in Cash | $2.08B | $1.04B | $1.61B | $327.00M | $-1.13B | $65.00M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $13.47B | - | $37.65B | - |
| Cost of Revenue | $8.11B | - | $22.66B | - |
| Operating Expenses | $12.35B | - | $33.86B | - |
| Research & Development | $862.00M | - | $2.52B | - |
| Operating Income | $1.11B | - | $3.79B | - |
| Interest Expense | $112.00M | - | $373.00M | - |
| Other Income/Expense | $1.62B | - | $2.04B | - |
| Income Before Tax | $2.62B | - | $5.51B | - |
| Income Tax Expense | $-4.05B | - | $-4.31B | - |
| Net Income | $6.63B | - | $9.76B | - |
| Basic EPS | 3.18 | - | 4.67 | - |
| Diluted EPS | 3.11 | - | 4.57 | - |
| Basic Shares Outstanding | $2.08B | - | $2.09B | - |
| Diluted Shares Outstanding | $2.12B | - | $2.12B | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $8.43B | $5.89B |
| Short-term Investments | $654.00M | $1.08B |
| Accounts Receivable | $3.77B | $3.33B |
| Other Current Assets | $1.80B | $1.39B |
| Total Current Assets | $15.14B | $12.24B |
| Goodwill | $8.92B | $8.07B |
| Intangible Assets | $1.10B | $1.12B |
| Other Non-current Assets | $3.32B | $2.57B |
| Total Assets | $63.34B | $51.24B |
| Accounts Payable | $1.12B | $858.00M |
| Total Current Liabilities | $13.12B | $11.48B |
| Long-term Debt | $10.62B | $8.35B |
| Other Non-current Liabilities | $430.00M | $449.00M |
| Total Liabilities | $34.19B | $28.77B |
| Common Stock | - | - |
| Retained Earnings | $-10.94B | $-20.73B |
| Total Stockholders Equity | $28.13B | $21.56B |
| Total Liabilities & Equity | $63.34B | $51.24B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $6.63B | - | $9.76B | - |
| Depreciation & Amortization | $188.00M | - | $534.00M | - |
| Stock-based Compensation | - | - | $1.38B | - |
| Deferred Income Tax | - | - | $-4.49B | - |
| Change in Receivables | - | - | $357.00M | - |
| Change in Payables | - | - | $232.00M | - |
| Operating Cash Flow | - | - | $7.22B | - |
| Capital Expenditure | - | - | $261.00M | - |
| Acquisitions | - | - | $804.00M | - |
| Purchases of Investments | - | - | $13.95B | - |
| Investing Cash Flow | - | - | $-1.95B | - |
| Debt Repayment | - | - | $1.20B | - |
| Stock Repurchased | - | - | $4.61B | - |
| Financing Cash Flow | - | - | $-2.60B | - |
| Net Change in Cash | - | - | $2.87B | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.